Refractory neuroblastoma Clinical Trials

Delta Trials records 35 clinical trials for Refractory neuroblastoma in its publicly accessible dataset. From the full dataset, 8 actively seeking eligible participants and 12 trials have reached completion. This research is conducted across 157 study locations around the world. An additional 15 trials are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.